Vaishali Pharma Management
Management Kriterienprüfungen 2/4
Wir verfügen derzeit nicht über ausreichende Informationen über den CEO.
Wichtige Informationen
Hemanth Pathak
Geschäftsführender
n/a
Gesamtvergütung
| Prozentsatz des Geschäftsführergehalts | n/a |
| Amtszeit als Geschäftsführer | 4.3yrs |
| Eigentum des Geschäftsführers | n/a |
| Durchschnittliche Amtszeit des Managements | 4.3yrs |
| Durchschnittliche Amtszeit der Vorstandsmitglieder | 5.6yrs |
Jüngste Management Updates
Recent updates
A Piece Of The Puzzle Missing From Vaishali Pharma Limited's (NSE:VAISHALI) 27% Share Price Climb
Sep 13
The Market Lifts Vaishali Pharma Limited (NSE:VAISHALI) Shares 26% But It Can Do More
Jul 05Here's Why Vaishali Pharma (NSE:VAISHALI) Has Caught The Eye Of Investors
Jan 17Vaishali Pharma Limited's (NSE:VAISHALI) Shares Leap 30% Yet They're Still Not Telling The Full Story
Dec 18Is Vaishali Pharma (NSE:VAISHALI) A Risky Investment?
Dec 11We Ran A Stock Scan For Earnings Growth And Vaishali Pharma (NSE:VAISHALI) Passed With Ease
Oct 04With EPS Growth And More, Vaishali Pharma (NSE:VAISHALI) Makes An Interesting Case
Feb 04Vaishali Pharma (NSE:VAISHALI) Seems To Use Debt Quite Sensibly
Dec 10We Ran A Stock Scan For Earnings Growth And Vaishali Pharma (NSE:VAISHALI) Passed With Ease
Aug 20Should You Be Adding Vaishali Pharma (NSE:VAISHALI) To Your Watchlist Today?
May 19These 4 Measures Indicate That Vaishali Pharma (NSE:VAISHALI) Is Using Debt Reasonably Well
Feb 10A Look At The Intrinsic Value Of Vaishali Pharma Limited (NSE:VAISHALI)
Aug 17A Look At The Fair Value Of Vaishali Pharma Limited (NSE:VAISHALI)
May 17Are Vaishali Pharma Limited's (NSE:VAISHALI) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?
Mar 17Calculating The Fair Value Of Vaishali Pharma Limited (NSE:VAISHALI)
Feb 15Does Vaishali Pharma (NSE:VAISHALI) Have A Healthy Balance Sheet?
Jan 19
Are Vaishali Pharma Limited's (NSE:VAISHALI) Mixed Financials Driving The Negative Sentiment?
Nov 23Geschäftsführer
Hemanth Pathak (63 yo)
4.3yrs
Amtszeit
Mr. Hemanth Damodar Pathak serves as Chief Executive Officer of Vaishali Pharma Limited from May 26, 2020. He has good experience in the field International Business Development as exposure to more than 90...
Führungsteam
| Name | Position | Amtszeit | Vergütung | Eigentümerschaft |
|---|---|---|---|---|
| Chairman & MD | 16.4yrs | ₹6.43m | 18.73% ₹ 455.6m | |
| Chief Executive Officer | 4.3yrs | keine Daten | keine Daten | |
| Chief Financial Officer | 7.3yrs | ₹901.00k | keine Daten | |
| Company Secretary & Compliance Officer | 2.8yrs | ₹504.00k | keine Daten | |
| Whole Time Director | 14.8yrs | ₹1.61m | 5.62% ₹ 136.7m | |
| Executive Director | 3.1yrs | ₹1.16m | 0.000010% ₹ 243.2 | |
| Chief Operating Officer | no data | keine Daten | 0.000010% ₹ 243.2 |
4.3yrs
Durchschnittliche Betriebszugehörigkeit
43yo
Durchschnittliches Alter
Erfahrenes Management: VAISHALIDas Führungsteam des Unternehmens gilt als erfahren (4 Jahre durchschnittliche Betriebszugehörigkeit).
Vorstandsmitglieder
| Name | Position | Amtszeit | Vergütung | Eigentümerschaft |
|---|---|---|---|---|
| Chairman & MD | 16.4yrs | ₹6.43m | 18.73% ₹ 455.6m | |
| Whole Time Director | 16.4yrs | ₹1.61m | 5.62% ₹ 136.7m | |
| Executive Director | 6.4yrs | ₹1.16m | 0.000010% ₹ 243.2 | |
| Non Executive & Independent Director | 4.8yrs | ₹6.60k | keine Daten | |
| Non-Executive & Independent Director | 4.8yrs | ₹6.60k | keine Daten | |
| Non-Executive & Independent Director | 3.2yrs | ₹6.60k | keine Daten |
5.6yrs
Durchschnittliche Betriebszugehörigkeit
56.5yo
Durchschnittliches Alter
Erfahrener Vorstand: VAISHALIDie Vorstandsmitglieder gelten als erfahren (5.3 Jahre durchschnittliche Amtszeit).